In the CD cohort of the RELIEVE UCCD study, 26% (450 mg dose) and 48% (900 mg dose) of patients treated with duvakitug achieved the primary endpoint of endoscopic response (SES-CD)* compared to 13% on ...

Sulforaphane, a compound found in broccoli sprouts, may help lower blood sugar levels in people with prediabetes, a new study ...

Real Housewives of New Jersey star Dolores Catania has reached her high school weight after two years on the medication. She ...

The Smithsonian’s decision to change the name of a work by Félix González-Torres – cancelling out the express tribute to his ...

Acute respiratory infections (ARIs) are a common cause of illness in children younger than 16 years and adults older than 65 ...

Placebo frontman Brian Molko has been charged with defamation by Italian prosecutors after calling Italian Prime Minister ...

Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustain ...

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...

MSM supplements may help with joint pain and swelling, but some experts aren't convinced. What you should know about how they ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.